General Counsel For Biopharma Biz Incyte Set To Retire
Biopharmaceutical company Incyte's general counsel is set to retire Nov. 1, but may end her duties in the multiple roles she serves earlier, pending the appointment of her successor, according to...To view the full article, register now.
Already a subscriber? Click here to view full article